The gut in iron homeostasis: Role of HIF-2 under normal and pathological conditions

Blood

Volumn 122, Issue 6, 2013, Pages 885-892

  Mastrogiannaki, Maria ^a,b,c   Matak, Pavle ^a,b,c   Peyssonnaux, Carole ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON; ANTIMICROBIAL CATIONIC PEPTIDE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; IRP1 PROTEIN, HUMAN; IRP2 PROTEIN, HUMAN;

ARTICLE; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; INFLAMMATION; INTESTINE; INTESTINE CELL; IRON ABSORPTION; IRON DEFICIENCY; MOLECULAR MECHANICS; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEADY STATE; ANIMAL; ANOXIA; CYTOLOGY; GASTROINTESTINAL TRACT; LIVER CELL; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; ANOXIA; ANTIMICROBIAL CATIONIC PEPTIDES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ENTEROCYTES; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; HEPATOCYTES; HOMEOSTASIS; HUMANS; INFLAMMATION; IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MALE; MICE; POLYCYTHEMIA;

EID: 84886902763     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-11-427765     Document Type: Article

References (100)

1. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008; 112(2): 219-230.
2. Anderson GJ, Darshan D, Wilkins S.J., Frazer DM. Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals. 2007; 20(3-4): 665-674. (Pubitemid 46776558)
3. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012; 1823(9): 1434-1443.
4. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704): 2090-2093. (Pubitemid 40007660)
5. Sharp PA. Intestinal iron absorption: regulation by dietary & systemic factors. Int J Vitam Nutr Res. 2010; 80(4-5): 231-242.
6. Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr. 2003; 23: 283-301. (Pubitemid 37059725)
7. McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science. 2001; 291(5509): 1755-1759. (Pubitemid 32198974)
8. Gunshin H, Starr CN, Direnzo C, et al. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood. 2005; 106(8): 2879-2883. (Pubitemid 41510768)
9. Choi J, Masaratana P, Latunde-Dada GO, Arno M., Simpson RJ, McKie AT. Duodenal reductase activity and spleen iron stores are reduced and erythropoiesis is abnormal in Dcytb knockout mice exposed to hypoxic conditions. J Nutr. 2012; 142(11): 1929-1934.
10. Knutson MD. Steap proteins: implications for iron and copper metabolism. Nutr Rev. 2007; 65(7): 335-340. (Pubitemid 351804358)
11. Gunshin H, Mackenzie B, Berger U.V., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997; 388(6641): 482-488. (Pubitemid 27328927)
12. Gunshin H, Fujiwara Y, Custodio A.O., Direnzo C., Robine S, Andrews NC. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005; 115(5): 1258-1266. (Pubitemid 40629044)
13. Iolascon A, d'Apolito M, Servedio V, Cimmino F., Piga A, Camaschella C. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood. 2006; 107(1): 349-354. (Pubitemid 43053562)
14. Blanco E, Kannengiesser C, Grandchamp B., Tasso M, Beaumont C. Not all DMT1 mutations lead to iron overload. Blood Cells Mol Dis. 2009; 43(2): 199-201.
15. McKie AT, Marciani P, Rolfs A., et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000; 5(2): 299-309. (Pubitemid 30628088)
16. Vanoaica L, Darshan D, Richman L., Schümann K, Kühn LC. Intestinal ferritin H is required for an accurate control of iron absorption. Cell Metab. 2010; 12(3): 273-282.
17. Donovan A, Lima CA, Pinkus J.L., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005; 1(3): 191-200. (Pubitemid 43960600)
18. Yeh KY, Yeh M, Mims L., Glass J. Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium. Am J Physiol Gastrointest Liver Physiol. 2009; 296(1): G55-G65.
19. Chen H, Huang G, Su T., et al. Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J Nutr. 2006; 136(5): 1236-1241.
20. Conrad ME, Umbreit JN. Pathways of iron absorption. Blood Cells Mol Dis. 2002; 29(3): 336-355.
21. Qiu A, Jansen M, Sakaris A., et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006; 127(5): 917-928. (Pubitemid 44792250)
22. Yanatori I, Tabuchi M, Kawai Y., Yasui Y, Akagi R, Kishi F. Heme and non-heme iron transporters in non-polarized and polarized cells. BMC Cell Biol. 2010; 11: 39.
23. White C, Yuan X, Schmidt P.J., et al. HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. Cell Metab. 2013; 17(2): 261-270.
24. Quigley JG, Yang Z, Worthington M.T., et al. Identification of a human heme exporter that is essential for erythropoiesis. Cell. 2004; 118(6): 757-766. (Pubitemid 39221734)
25. Faura J, Ramos J, Reynafarje C., English E, Finne P, Finch CA. Effect of altitude on erythropoiesis. Blood. 1969; 33(5): 668-676.
26. Latunde-Dada G.O., Vulpe CD, Anderson G.J., Simpson RJ, McKie AT. Tissue-specific changes in iron metabolism genes in mice following phenylhydrazine-induced haemolysis. Biochim Biophys Acta. 2004; 1690(2): 169-176. (Pubitemid 39299195)
27. Leung PS, Srai SK, Mascarenhas M, Churchill L.J., Debnam ES. Increased duodenal iron uptake and transfer in a rat model of chronic hypoxia is accompanied by reduced hepcidin expression. Gut. 2005; 54(10): 1391-1395. (Pubitemid 41375194)
28. Zoller H, Theurl I, Koch R., Kaser A, Weiss G. Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Dis. 2002; 29(3): 488-497.
29. Taylor M, Qu A, Anderson E.R., et al. Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology. 2011; 140(7): 2044-2055.
30. Lesbordes-Brion J.C., Viatte L, Bennoun M., et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood. 2006; 108(4): 1402-1405. (Pubitemid 44232044)
31. Frazer DM, Wilkins SJ, Becker E.M., et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology. 2002; 123(3): 835-844. (Pubitemid 34977090)
32. Viatte L, Lesbordes-Brion JC, Lou D.Q., et al. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood. 2005; 105(12): 4861-4864. (Pubitemid 40807315)
33. Chaston T, Chung B, Mascarenhas M., et al. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut. 2008; 57(3): 374-382. (Pubitemid 351288105)
34. Mena NP, Esparza A, Tapia V., Valdés P, Núñez MT. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2008; 294(1):G192-G198.
35. Brasse-Lagnel C., Karim Z, Letteron P., Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology. 2011; 140(4): 1261-1271.e1.
36. Foot NJ, Dalton HE, Shearwin-Whyatt LM, et al. Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood. 2008; 112(10): 4268-4275.
37. Hathorn MK. The influence of hypoxia on iron absorption in the rat. Gastroenterology. 1971; 60(1): 76-81.
38. Raja KB, Simpson RJ, Pippard M.J., Peters TJ. In vivo studies on the relationship between intestinal iron (Fe3+) absorption, hypoxia and erythropoiesis in the mouse. Br J Haematol. 1988; 68(3): 373-378.
39. Nicolas G, Chauvet C, Viatte L., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110(7): 1037-1044.
40. Piperno A, Galimberti S, Mariani R., et al.; HIGHCARE investigators. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood. 2011; 117(10): 2953-2959.
41. Talbot NP, Lakhal S, Smith T.G., et al. Regulation of hepcidin expression at high altitude. Blood. 2012; 119(3): 857-860.
42. Simpson RJ. Dietary iron levels and hypoxia independently affect iron absorption in mice. J Nutr. 1996; 126(7): 1858-1864. (Pubitemid 26231453)
43. Srai SK, Chung B, Marks J., et al. Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure. Kidney Int. 2010; 78(7): 660-667.
44. Frazer DM, Wilkins SJ, Becker E.M., et al. A rapid decrease in the expression of DMT1 and Dcytb but not Ireg1 or hephaestin explains the mucosal block phenomenon of iron absorption. Gut. 2003; 52(3): 340-346. (Pubitemid 36250051)
45. Kaelin WG J.r., Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008; 30(4): 393-402. (Pubitemid 351681994)
46. Epstein AC, Gleadle JM, McNeill L.A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107(1): 43-54. (Pubitemid 32972036)
47. Maxwell PH, Wiesener MS, Chang G.W., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733): 271-275. (Pubitemid 29246458)
48. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001; 15(20): 2675-2686. (Pubitemid 32988878)
49. Dayan F, Roux D, Brahimi-Horn MC, Pouyssegur J., Mazure NM. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res. 2006; 66(7): 3688-3698.
50. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE. 2005; 2005(306):re12.
51. Peyssonnaux C, Nizet V, Johnson RS. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle. 2008; 7(1): 28-32.
52. Mastrogiannaki M, Matak P, Keith B., Simon MC, Vaulont S, Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest. 2009; 119(5): 1159-1166.
53. Shah YM, Matsubara T, Ito S., Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009; 9(2): 152-164.
54. Mastrogiannaki M, Matak P, Delga S., Deschemin JC, Vaulont S, Peyssonnaux C. Deletion of HIF-2α in the enterocytes decreases the severity of tissue iron loading in hepcidin knockout mice. Blood. 2012; 119(2): 587-590.
55. Hu CJ, Sataur A, Wang L., Chen H, Simon MC. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell. 2007; 18(11): 4528-4542. (Pubitemid 350060179)
56. Matak P, Deschemin JC, Peyssonnaux C, Vaulont S. Lack of iron-related phenotype in Sp6 intestinal knockout mice. Blood Cells Mol Dis. 2011; 47(1): 46-49.
57. Parks SK, Chiche J, Pouyssegur J. pH control mechanisms of tumor survival and growth. J Cell Physiol. 2011; 226(2): 299-308.
58. Anderson ER, Xue X, Shah YM. Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis. J Biol Chem. 2011; 286(22): 19533-19540.
59. Wiesener MS, Jürgensen JS, Rosenberger C., et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 2003; 17(2): 271-273.
60. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010; 142(1): 24-38.
61. Anderson CP, Shen M, Eisenstein R.S., Leibold EA. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta. 2012; 1823(9): 1468-1483.
62. Vashisht AA, Zumbrennen KB, Huang X, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science. 2009; 326(5953): 718-721.
63. Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh M.C., Rouault TA. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab. 2009; 9(5): 461-473.
64. Galy B, Ferring-Appel D, Kaden S., Gröne HJ, Hentze MW. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab. 2008; 7(1): 79-85.
65. Galy B, Ferring D, Minana B., et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood. 2005; 106(7): 2580-2589. (Pubitemid 41510837)
66. Ferring-Appel D., Hentze MW, Galy B. Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism. Blood. 2009; 113(3): 679-687.
67. Sanchez M, Galy B, Muckenthaler M.U., Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat Struct Mol Biol. 2007; 14(5): 420-426. (Pubitemid 46685876)
68. Davis MR, Shawron KM, Rendina E, et al. Hypoxia inducible factor-2 a is translationally repressed in response to dietary iron deficiency in Sprague-Dawley rats. J Nutr. 2011; 141(9): 1590-1596.
69. Anderson SA, Nizzi CP, Chang Y.I., et al. The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab. 2013; 17(2): 282-290.
70. Ghosh MC, Zhang DL, Jeong S.Y., et al. Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2α. Cell Metab. 2013; 17(2): 271-281.
71. Galy B, Ferring-Appel D, Becker C., et al. Iron regulatory proteins control a mucosal block to intestinal iron absorption. Cell Rep. 2013; 3(3): 844-857.
72. Recalcati S, Alberghini A, Campanella A., et al. Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency. Haematologica. 2006; 91(3): 303-310.
73. Luo QQ, Wang D, Yu M.Y., Zhu L. Effect of hypoxia on the expression of iron regulatory proteins 1 and the mechanisms involved. IUBMB Life. 2011; 63(2): 120-128.
74. Matak P, Zumerle S, Mastrogiannaki M., et al. Copper deficiency leads to anemia, duodenal hypoxia, upregulation of HIF-2α and altered expression of iron absorption genes in mice. PLoS ONE. 2013; 8(3):e59538.
75. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta. 2009; 1790(7): 682-693.
76. Nemeth E, Rivera S, Gabayan V., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113(9): 1271-1276. (Pubitemid 39069926)
77. Rivera S, Ganz T. Animal models of anemia of inflammation. Semin Hematol. 2009; 46(4): 351-357.
78. Rivera S, Liu L, Nemeth E., Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood. 2005; 105(4): 1797-1802. (Pubitemid 40223704)
79. Roy CN, Mak HH, Akpan I, Losyev G., Zurakowski D, Andrews NC. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 2007; 109(9): 4038-4044. (Pubitemid 46641759)
80. Rivera S, Nemeth E, Gabayan V., Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005; 106(6): 2196-2199. (Pubitemid 41291740)
81. Johnson D, Bayele H, Johnston K., Tennant J, Srai SK, Sharp P. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett. 2004; 573(1-3): 195-201. (Pubitemid 39141057)
82. Laftah AH, Sharma N, Brookes M.J., et al. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem J. 2006; 397(1): 61-67. (Pubitemid 44032837)
83. Schubert TE, Bosserhoff AK, Peyssonaux C, et al. Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Rep. 2012; 6(4): 838-842.
84. Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med (Berl). 2007; 85(12): 1295-1300. (Pubitemid 50004090)
85. Styś A, Galy B, Starzyński RR, et al. Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide. J Biol Chem. 2011; 286(26): 22846-22854.
86. Reynafarje C, Lozano R, Valdivieso J. The polycythemia of high altitudes: iron metabolism and related aspects. Blood. 1959; 14(4): 433-455.
87. Beall CM, Cavalleri GL, Deng L, et al. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci USA. 2010; 107(25): 11459-11464.
88. Simonson TS, Yang Y, Huff C.D., et al. Genetic evidence for high-altitude adaptation in Tibet. Science. 2010; 329(5987): 72-75.
89. Ginzburg Y, Rivella S. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood. 2011; 118(16): 4321-4330.
90. Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007; 109(11): 5027-5035. (Pubitemid 46827803)
91. Tanno T, Bhanu NV, Oneal P.A., et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007; 13(9): 1096-1101. (Pubitemid 47517510)
92. Babitt JL, Lin HY. The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis. 2011; 31(3): 280-292.
93. De Domenico I., Ward DM, Nemeth E, et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA. 2005; 102(25): 8955-8960. (Pubitemid 40881060)
94. Rankin EB, Rha J, Selak M.A., et al. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol. 2009; 29(16): 4527-4538.
95. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest. 2000; 105(9): 1209-1216. (Pubitemid 30266073)
96. Constantine CC, Anderson GJ, Vulpe C.D., et al. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol. 2009; 147(1): 140-149.
97. Zimmer M, Ebert BL, Neil C, et al. Small-molecule inhibitors of HIF-2α translation link its 5'UTR iron-responsive element to oxygen sensing. Mol Cell. 2008; 32(6): 838-848.
98. Vachal P, Miao S, Pierce J.M., et al. 1,3,8-Triazaspiro[4.5]decane-2,4- diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia. J Med Chem. 2012; 55(7): 2945-2959.
99. Denny WA. Giving anemia a boost with inhibitors of prolyl hydroxylase. J Med Chem. 2012; 55(7): 2943-2944.
100. Kapitsinou PP, Liu Q, Unger T.L., et al. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood. 2010; 116(16): 3039-3048.